PubMed:9127005
Annnotations
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-119 | Sentence | denotes | Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent. |
| T2 | 120-338 | Sentence | denotes | Assembly of terminal complement complexes (TCC) C5b-7, C5b-8, and C5b-9 on target cells during acute and chronic inflammation induces hydrolysis of plasma membrane phospholipids and heterotrimeric G protein activation. |
| T3 | 339-475 | Sentence | denotes | TCC also stimulate a variety of cellular activities, which include cytokine synthesis, proto-oncogene activation, and mitotic signaling. |
| T4 | 476-609 | Sentence | denotes | Now we report that sublytic TCC induced Ras, Raf-1, and extracellular signal-regulated kinase (ERK) 1 activation in JY25 B cell line. |
| T5 | 610-806 | Sentence | denotes | When cells were exposed to C5b-9, GTP-bound Ras in anti-C5b-9 immunoprecipitates was increased 3.2-fold at 2 min, while GTP-bound Ras in anti-Ras immunoprecipitates was increased 2-fold at 10 min. |
| T6 | 807-937 | Sentence | denotes | Both C5b-9 and C5b-7, but not C5b6, increased Raf-1 kinase activity maximum 3.3-fold at 2 min and 2.8-fold at 5 min, respectively. |
| T7 | 938-1035 | Sentence | denotes | ERK1 activity was 2-fold increased by C5b-9 at 2 min and by C5b-7 at 10 min, over the C5b6 level. |
| T8 | 1036-1224 | Sentence | denotes | The role of mitogen-activated protein kinase (MAPK) pathway on TCC-inducible mitotic signaling was evaluated by assessing DNA synthesis and activator protein 1 (AP-1) DNA-binding activity. |
| T9 | 1225-1310 | Sentence | denotes | The MAPK/ERK-specific inhibitor PD 098,059 abolished the C5b-9-induced DNA synthesis. |
| T10 | 1311-1515 | Sentence | denotes | Involvement of G protein in the activation of MAPK pathway by TCC was indicated by inhibition of Raf-1 and ERK1 kinase activity, as well as the DNA synthesis by pretreatment of cells with pertussis toxin. |
| T11 | 1516-1815 | Sentence | denotes | Overexpression of beta-adrenergic receptor kinase 1 carboxyl-terminal peptide in JY25 cells also inhibited Raf-1 and ERK1 activity, indicating a direct involvement of G betagamma subunits in the signal transduction generated through activation of MAPK pathway by TCC assembly in the plasma membrane. |
| T1 | 0-119 | Sentence | denotes | Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent. |
| T2 | 120-338 | Sentence | denotes | Assembly of terminal complement complexes (TCC) C5b-7, C5b-8, and C5b-9 on target cells during acute and chronic inflammation induces hydrolysis of plasma membrane phospholipids and heterotrimeric G protein activation. |
| T3 | 339-475 | Sentence | denotes | TCC also stimulate a variety of cellular activities, which include cytokine synthesis, proto-oncogene activation, and mitotic signaling. |
| T4 | 476-609 | Sentence | denotes | Now we report that sublytic TCC induced Ras, Raf-1, and extracellular signal-regulated kinase (ERK) 1 activation in JY25 B cell line. |
| T5 | 610-806 | Sentence | denotes | When cells were exposed to C5b-9, GTP-bound Ras in anti-C5b-9 immunoprecipitates was increased 3.2-fold at 2 min, while GTP-bound Ras in anti-Ras immunoprecipitates was increased 2-fold at 10 min. |
| T6 | 807-937 | Sentence | denotes | Both C5b-9 and C5b-7, but not C5b6, increased Raf-1 kinase activity maximum 3.3-fold at 2 min and 2.8-fold at 5 min, respectively. |
| T7 | 938-1035 | Sentence | denotes | ERK1 activity was 2-fold increased by C5b-9 at 2 min and by C5b-7 at 10 min, over the C5b6 level. |
| T8 | 1036-1224 | Sentence | denotes | The role of mitogen-activated protein kinase (MAPK) pathway on TCC-inducible mitotic signaling was evaluated by assessing DNA synthesis and activator protein 1 (AP-1) DNA-binding activity. |
| T9 | 1225-1310 | Sentence | denotes | The MAPK/ERK-specific inhibitor PD 098,059 abolished the C5b-9-induced DNA synthesis. |
| T10 | 1311-1515 | Sentence | denotes | Involvement of G protein in the activation of MAPK pathway by TCC was indicated by inhibition of Raf-1 and ERK1 kinase activity, as well as the DNA synthesis by pretreatment of cells with pertussis toxin. |
| T11 | 1516-1815 | Sentence | denotes | Overexpression of beta-adrenergic receptor kinase 1 carboxyl-terminal peptide in JY25 cells also inhibited Raf-1 and ERK1 activity, indicating a direct involvement of G betagamma subunits in the signal transduction generated through activation of MAPK pathway by TCC assembly in the plasma membrane. |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 22-54 | protein | denotes | mitogen-activated protein kinase |
| T2 | 66-95 | protein | denotes | terminal complement complexes |
| T3 | 99-108 | protein | denotes | G protein |
| T4 | 132-161 | protein | denotes | terminal complement complexes |
| T5 | 163-166 | protein | denotes | TCC |
| T6 | 168-173 | protein | denotes | C5b-7 |
| T7 | 175-180 | protein | denotes | C5b-8 |
| T8 | 186-191 | protein | denotes | C5b-9 |
| T9 | 317-326 | protein | denotes | G protein |
| T10 | 339-342 | protein | denotes | TCC |
| T11 | 406-414 | protein | denotes | cytokine |
| T12 | 426-440 | DNA | denotes | proto-oncogene |
| T13 | 504-507 | protein | denotes | TCC |
| T14 | 516-519 | protein | denotes | Ras |
| T15 | 521-526 | protein | denotes | Raf-1 |
| T16 | 532-577 | protein | denotes | extracellular signal-regulated kinase (ERK) 1 |
| T17 | 637-642 | protein | denotes | C5b-9 |
| T18 | 644-657 | protein | denotes | GTP-bound Ras |
| T19 | 661-690 | protein | denotes | anti-C5b-9 immunoprecipitates |
| T20 | 730-743 | protein | denotes | GTP-bound Ras |
| T21 | 747-774 | protein | denotes | anti-Ras immunoprecipitates |
| T22 | 812-817 | protein | denotes | C5b-9 |
| T23 | 822-827 | protein | denotes | C5b-7 |
| T24 | 837-841 | protein | denotes | C5b6 |
| T25 | 853-858 | protein | denotes | Raf-1 |
| T26 | 938-942 | protein | denotes | ERK1 |
| T27 | 976-981 | protein | denotes | C5b-9 |
| T28 | 998-1003 | protein | denotes | C5b-7 |
| T29 | 1024-1028 | protein | denotes | C5b6 |
| T30 | 1048-1080 | protein | denotes | mitogen-activated protein kinase |
| T31 | 1082-1086 | protein | denotes | MAPK |
| T32 | 1099-1102 | protein | denotes | TCC |
| T33 | 1176-1195 | protein | denotes | activator protein 1 |
| T34 | 1197-1201 | protein | denotes | AP-1 |
| T35 | 1282-1287 | protein | denotes | C5b-9 |
| T36 | 1326-1335 | protein | denotes | G protein |
| T37 | 1357-1361 | protein | denotes | MAPK |
| T38 | 1373-1376 | protein | denotes | TCC |
| T39 | 1408-1413 | protein | denotes | Raf-1 |
| T40 | 1418-1422 | protein | denotes | ERK1 |
| T41 | 1499-1514 | protein | denotes | pertussis toxin |
| T42 | 1597-1607 | cell_line | denotes | JY25 cells |
| T43 | 1623-1628 | protein | denotes | Raf-1 |
| T44 | 1633-1637 | protein | denotes | ERK1 |
| T45 | 1763-1767 | protein | denotes | MAPK |
| T46 | 1779-1782 | protein | denotes | TCC |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 22-62 | NP | denotes | mitogen-activated protein kinase pathway |
| C2 | 66-95 | NP | denotes | terminal complement complexes |
| C3 | 339-342 | NP | denotes | TCC |
| C4 | 371-390 | NP | denotes | cellular activities |
| C5 | 392-397 | NP | denotes | which |
| C6 | 592-608 | NP | denotes | JY25 B cell line |
| C7 | 637-642 | NP | denotes | C5b-9 |
| C8 | 644-657 | NP | denotes | GTP-bound Ras |
| C9 | 730-743 | NP | denotes | GTP-bound Ras |
| C10 | 812-817 | NP | denotes | C5b-9 |
| C11 | 822-827 | NP | denotes | C5b-7 |
| C12 | 976-981 | NP | denotes | C5b-9 |
| C13 | 998-1003 | NP | denotes | C5b-7 |
| C14 | 1048-1095 | NP | denotes | mitogen-activated protein kinase (MAPK) pathway |
| C16 | 1357-1369 | NP | denotes | MAPK pathway |
| C17 | 1373-1376 | NP | denotes | TCC |
| C15 | 1339-1376 | NP | denotes | the activation of MAPK pathway by TCC |
| C18 | 1408-1438 | NP | denotes | Raf-1 and ERK1 kinase activity |
| C19 | 1597-1607 | NP | denotes | JY25 cells |
| C20 | 1623-1646 | NP | denotes | Raf-1 and ERK1 activity |
| C22 | 1763-1775 | NP | denotes | MAPK pathway |
| C21 | 1749-1791 | NP | denotes | activation of MAPK pathway by TCC assembly |
| R1 | C3 | C2 | coref-ident | TCC,terminal complement complexes |
| R2 | C5 | C4 | coref-relat | which,cellular activities |
| R3 | C9 | C8 | coref-ident | GTP-bound Ras,GTP-bound Ras |
| R4 | C10 | C7 | coref-ident | C5b-9,C5b-9 |
| R5 | C12 | C10 | coref-ident | C5b-9,C5b-9 |
| R6 | C13 | C11 | coref-ident | C5b-7,C5b-7 |
| R7 | C14 | C1 | coref-ident | mitogen-activated protein kinase (MAPK) pathway,mitogen-activated protein kinase pathway |
| R8 | C16 | C14 | coref-ident | MAPK pathway,mitogen-activated protein kinase (MAPK) pathway |
| R9 | C17 | C3 | coref-ident | TCC,TCC |
| R10 | C19 | C6 | coref-ident | JY25 cells,JY25 B cell line |
| R11 | C20 | C18 | coref-ident | Raf-1 and ERK1 activity,Raf-1 and ERK1 kinase activity |
| R12 | C22 | C16 | coref-ident | MAPK pathway,MAPK pathway |
| R13 | C21 | C15 | coref-ident | activation of MAPK pathway by TCC assembly,the activation of MAPK pathway by TCC |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-119 | Sentence | denotes | Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent. |
| S2 | 120-338 | Sentence | denotes | Assembly of terminal complement complexes (TCC) C5b-7, C5b-8, and C5b-9 on target cells during acute and chronic inflammation induces hydrolysis of plasma membrane phospholipids and heterotrimeric G protein activation. |
| S3 | 339-475 | Sentence | denotes | TCC also stimulate a variety of cellular activities, which include cytokine synthesis, proto-oncogene activation, and mitotic signaling. |
| S4 | 476-609 | Sentence | denotes | Now we report that sublytic TCC induced Ras, Raf-1, and extracellular signal-regulated kinase (ERK) 1 activation in JY25 B cell line. |
| S5 | 610-806 | Sentence | denotes | When cells were exposed to C5b-9, GTP-bound Ras in anti-C5b-9 immunoprecipitates was increased 3.2-fold at 2 min, while GTP-bound Ras in anti-Ras immunoprecipitates was increased 2-fold at 10 min. |
| S6 | 807-937 | Sentence | denotes | Both C5b-9 and C5b-7, but not C5b6, increased Raf-1 kinase activity maximum 3.3-fold at 2 min and 2.8-fold at 5 min, respectively. |
| S7 | 938-1035 | Sentence | denotes | ERK1 activity was 2-fold increased by C5b-9 at 2 min and by C5b-7 at 10 min, over the C5b6 level. |
| S8 | 1036-1224 | Sentence | denotes | The role of mitogen-activated protein kinase (MAPK) pathway on TCC-inducible mitotic signaling was evaluated by assessing DNA synthesis and activator protein 1 (AP-1) DNA-binding activity. |
| S9 | 1225-1310 | Sentence | denotes | The MAPK/ERK-specific inhibitor PD 098,059 abolished the C5b-9-induced DNA synthesis. |
| S10 | 1311-1515 | Sentence | denotes | Involvement of G protein in the activation of MAPK pathway by TCC was indicated by inhibition of Raf-1 and ERK1 kinase activity, as well as the DNA synthesis by pretreatment of cells with pertussis toxin. |
| S11 | 1516-1815 | Sentence | denotes | Overexpression of beta-adrenergic receptor kinase 1 carboxyl-terminal peptide in JY25 cells also inhibited Raf-1 and ERK1 activity, indicating a direct involvement of G betagamma subunits in the signal transduction generated through activation of MAPK pathway by TCC assembly in the plasma membrane. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 22-54 | protein_family_or_group | denotes | mitogen-activated protein kinase |
| T2 | 66-95 | protein_complex | denotes | terminal complement complexes |
| T3 | 99-108 | protein_family_or_group | denotes | G protein |
| T4 | 132-161 | protein_complex | denotes | terminal complement complexes |
| T5 | 163-166 | protein_complex | denotes | TCC |
| T6 | 168-173 | protein_complex | denotes | C5b-7 |
| T7 | 175-180 | protein_complex | denotes | C5b-8 |
| T8 | 186-191 | protein_complex | denotes | C5b-9 |
| T9 | 225-245 | other_name | denotes | chronic inflammation |
| T10 | 268-297 | lipid | denotes | plasma membrane phospholipids |
| T11 | 302-316 | other_name | denotes | heterotrimeric |
| T12 | 317-326 | protein_family_or_group | denotes | G protein |
| T13 | 339-342 | protein_complex | denotes | TCC |
| T14 | 406-414 | protein_family_or_group | denotes | cytokine |
| T15 | 426-440 | DNA_family_or_group | denotes | proto-oncogene |
| T16 | 457-474 | other_name | denotes | mitotic signaling |
| T17 | 504-507 | protein_complex | denotes | TCC |
| T18 | 516-519 | protein_molecule | denotes | Ras |
| T19 | 521-526 | protein_molecule | denotes | Raf-1 |
| T20 | 532-577 | protein_molecule | denotes | extracellular signal-regulated kinase (ERK) 1 |
| T21 | 637-642 | protein_complex | denotes | C5b-9 |
| T22 | 644-653 | protein_molecule | denotes | GTP-bound |
| T23 | 654-657 | protein_molecule | denotes | Ras |
| T24 | 661-666 | protein_complex | denotes | anti- |
| T25 | 666-671 | protein_complex | denotes | C5b-9 |
| T26 | 730-739 | protein_molecule | denotes | GTP-bound |
| T27 | 740-743 | protein_molecule | denotes | Ras |
| T28 | 747-752 | protein_complex | denotes | anti- |
| T29 | 752-755 | protein_molecule | denotes | Ras |
| T30 | 812-817 | protein_complex | denotes | C5b-9 |
| T31 | 822-827 | protein_complex | denotes | C5b-7 |
| T32 | 837-841 | protein_complex | denotes | C5b6 |
| T33 | 853-858 | protein_molecule | denotes | Raf-1 |
| T34 | 938-942 | protein_molecule | denotes | ERK1 |
| T35 | 976-981 | protein_complex | denotes | C5b-9 |
| T36 | 998-1003 | protein_complex | denotes | C5b-7 |
| T37 | 1024-1028 | protein_complex | denotes | C5b6 |
| T38 | 1048-1080 | protein_family_or_group | denotes | mitogen-activated protein kinase |
| T39 | 1082-1086 | protein_family_or_group | denotes | MAPK |
| T40 | 1099-1102 | protein_complex | denotes | TCC |
| T41 | 1113-1130 | other_name | denotes | mitotic signaling |
| T42 | 1176-1195 | protein_molecule | denotes | activator protein 1 |
| T43 | 1197-1201 | protein_molecule | denotes | AP-1 |
| T44 | 1229-1256 | other_organic_compound | denotes | MAPK/ERK-specific inhibitor |
| T45 | 1257-1267 | other_organic_compound | denotes | PD 098,059 |
| T46 | 1282-1287 | protein_complex | denotes | C5b-9 |
| T47 | 1326-1335 | protein_family_or_group | denotes | G protein |
| T48 | 1357-1361 | protein_family_or_group | denotes | MAPK |
| T49 | 1373-1376 | protein_complex | denotes | TCC |
| T50 | 1408-1413 | protein_molecule | denotes | Raf-1 |
| T51 | 1418-1422 | protein_molecule | denotes | ERK1 |
| T52 | 1455-1468 | other_name | denotes | DNA synthesis |
| T53 | 1499-1514 | protein_molecule | denotes | pertussis toxin |
| T54 | 1534-1593 | peptide | denotes | beta-adrenergic receptor kinase 1 carboxyl-terminal peptide |
| T55 | 1597-1607 | cell_line | denotes | JY25 cells |
| T56 | 1623-1628 | protein_molecule | denotes | Raf-1 |
| T57 | 1633-1637 | protein_molecule | denotes | ERK1 |
| T58 | 1763-1767 | protein_family_or_group | denotes | MAPK |
| T59 | 1779-1782 | protein_complex | denotes | TCC |
| T60 | 1799-1814 | cell_component | denotes | plasma membrane |